The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.

The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.

Regeneron COVID-19 treatment was given to President Donald Trump when he was sick by the virus
Regeneron COVID-19 treatment was given to President Donald Trump when he was sick by the virus

The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.

Regeneron’s drug is a combination of two monoclonal antibodies. A similar drug developed by Eli Lilly & Co. gained FDA emergency clearance earlier this month.

SEE ALSO

Pfizer
Pfizer

THE ULTIMATE CURE – Pfizer Says COVID-19 Vaccine Far More Effective Now At 95% Without Serious Side Effects

However the Regeneron treatment may not be immediately widely available: the company has said it will have just 80,000 doses by the end of November.

LEAVE A REPLY

Please enter your comment!
Please enter your name here